2015•Zhongguo xiaoer jijiu yixueRequires access

Detection of serum procalcitonin, C-reactive protein and white blood cell for severe pneumonia in children

Weiwei Tong, Guanghui Tong, Xiaosong Qin, Liping Lü

Open publisher page 0 citations

Abstract

Objective To explore the clinical effect of detection of serum procalcitonin (PCT), C-reactive protein (CRP) and white blood cell (WBC) on diagnosis and treatment of severe pneumonia in children. Methods A total of 189 cases of pediatric patients with pneumonia including 51 severe pneumonia cases (severe pneumonia group) and 138 common pneumonia cases (common pneumonia group) treated from Mar 2014 to Dec 2014 and 30 healthy cases ( control group) were enrolled, and the level of PCT, CRP and WBC of all cases were detected. Results The levels of PCT before treatment in severe pneumonia group, common pneumonia group, and control group were 1.12(0.44~3.07) ng/ml, 0.14(0.09~0.26) ng/ml and 0.03(0.01~0.06) ng/ml respectively, and there were significant differences among three groups (P<0.05, respectively). The levels of CRP before treatment in severe pneumonia group, common pneumonia group, and control group were 82.2(25.9~120.3) mg/L, 10.8(5.3~23.9) mg/L and 3.2(2.1~6.9) mg/L respectively, and there were significant differences among three groups (P<0.05, respectively). The counts of WBC before treatment in severe pneumonia group, common pneumonia group, and control group were 10.1(9.1~14.1)×109/L, 8.8(6.8~11.7)×109/L and 6.2(4.8~7.9)×109/L respectively, and there was significant difference only between severe pneumonia group and control group (P<0.05). The level of PCT and CRP significantly decreased in severe pneumonia group after one week of treatment[PCT: 0.15(0.09~0.24) ng/ml, CRP: 9.9(3.6~19.0) mg/L](P<0.05), but there was no significant difference of WBC counts in severe pneumonia group between after and before treatment[8.5(6.3~9.8)×109/L vs.10.1(9.1~14.1)×109/L](t=1.312, P=0.205). After two days of anti-inflammatory treatment in severe pneumonia group, serum PCT dropped to 44% of the level before treatment, and smoothly dropped to nearly 10% of the basic value every two days.Serum PCT was correlated with serum CRP in children with pneumonia(R2=0.550 4, P<0.05). Conclusion The combined detection of PCT and CRP could provide important guidance for the differential diagnosis, treatment and prognosis for severe pneumonia in children. Key words: Procalcitonin; C-reactive protein; White blood cell; Severe pneumonia

About this research paper

What this paper is about

Objective To explore the clinical effect of detection of serum procalcitonin (PCT), C-reactive protein (CRP) and white blood cell (WBC) on diagnosis and treatment of severe pneumonia in children. Methods A total of 189 cases of pediatric patients with pneumonia including 51 severe pneumonia cases (severe pneumonia group) and 138 common pneumonia cases (common pneumonia group) treated from Mar 2014 to Dec 2014 and 30 healthy cases ( control group) were enrolled, and the level of PCT, CRP and WBC of all cases were detected. Results The levels of PCT before treatment in severe pneumonia group, common pneumonia group, and control group were 1.12(0.44~3.07) ng/ml, 0.14(0.09~0.26) ng/ml and 0.03(0.01~0.06) ng/ml respectively, and there were significant differences among three groups (P<0.05, respectively). The levels of CRP before treatment in severe pneumonia group, common pneumonia group, and control group were 82.2(25.9~120.3) mg/L, 10.8(5.3~23.9) mg/L and 3.2(2.1~6.9) mg/L respectively, and there were significant differences among three groups (P<0.05, respectively). The counts of WBC before treatment in severe pneumonia group, common pneumonia group, and control group were 10.1(9.1~14.1)×109/L, 8.8(6.8~11.7)×109/L and 6.2(4.8~7.9)×109/L respectively, and there was significant difference only between severe pneumonia group and control group (P<0.05). The level of PCT and CRP significantly decreased in severe pneumonia group after one week of treatment[PCT: 0.15(0.09~0.24) ng/ml, CRP: 9.9(3.6~19.0) mg/L](P<0.05), but there was no significant difference of WBC counts in severe pneumonia group between after and before treatment[8.5(6.3~9.8)×109/L vs.10.1(9.1~14.1)×109/L](t=1.312, P=0.205). After two days of anti-inflammatory treatment in severe pneumonia group, serum PCT dropped to 44% of the level before treatment, and smoothly dropped to nearly 10% of the basic value every two days.Serum PCT was correlated with serum CRP in children with pneumonia(R2=0.550 4, P<0.05). Conclusion The combined detection of PCT and CRP could provide important guidance for the differential diagnosis, treatment and prognosis for severe pneumonia in children. Key words: Procalcitonin; C-reactive protein; White blood cell; Severe pneumonia

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical effect of detection of serum procalcitonin (PCT), C-reactive protein (CRP) and white blood cell (WBC) on diagnosis and treatment of severe pneumonia in children. Methods A total of 189 cases of pediatric patients with pneumonia including 51 severe pneumonia cases (severe pneumonia group) and 138 common pneumonia cases (common pneumonia group) treated from Mar 2014 to Dec 2014 and 30 healthy cases ( control group) were enrolled, and the level of PCT, CRP and WBC of all cases were detected. Results The levels of PCT before treatment in severe pneumonia group, common pneumonia group, and control group were 1.12(0.44~3.07) ng/ml, 0.14(0.09~0.26) ng/ml and 0.03(0.01~0.06) ng/ml respectively, and there were significant differences among three groups (P<0.05, respectively). The levels of CRP before treatment in severe pneumonia group, common pneumonia group, and control group were 82.2(25.9~120.3) mg/L, 10.8(5.3~23.9) mg/L and 3.2(2.1~6.9) mg/L respectively, and there were significant differences among three groups (P<0.05, respectively). The counts of WBC before treatment in severe pneumonia group, common pneumonia group, and control group were 10.1(9.1~14.1)×109/L, 8.8(6.8~11.7)×109/L and 6.2(4.8~7.9)×109/L respectively, and there was significant difference only between severe pneumonia group and control group (P<0.05). The level of PCT and CRP significantly decreased in severe pneumonia group after one week of treatment[PCT: 0.15(0.09~0.24) ng/ml, CRP: 9.9(3.6~19.0) mg/L](P<0.05), but there was no significant difference of WBC counts in severe pneumonia group between after and before treatment[8.5(6.3~9.8)×109/L vs.10.1(9.1~14.1)×109/L](t=1.312, P=0.205). After two days of anti-inflammatory treatment in severe pneumonia group, serum PCT dropped to 44% of the level before treatment, and smoothly dropped to nearly 10% of the basic value every two days.Serum PCT was correlated with serum CRP in children with pneumonia(R2=0.550 4, P<0.05). Conclusion The combined detection of PCT and CRP could provide important guidance for the differential diagnosis, treatment and prognosis for severe pneumonia in children. Key words: Procalcitonin; C-reactive protein; White blood cell; Severe pneumonia

Key concepts: Procalcitonin, Pneumonia, Medicine, White blood cell, Internal medicine, Gastroenterology, C-reactive protein, Inflammation

Related papers

Back to paper searchBrowse research topicsOriginal source
Detection of serum procalcitonin, C-reactive protein and white blood cell for severe pneumonia in children — Research Paper | ScholarLens